Javier Milei’s Bitcoin Blunder: Money, Not Securityby John Darbie 07.04.2024Bitcoin is declared as money, not a security by Javier Milei. However, his lack of understanding may lead to negative ...
April’s Apple Releases: iPad Watch & More!by Lilu Anderson 07.04.2024Rumors suggest that iOS 17.5 and macOS 14.5 will be released in April, but there were no beta versions following ...
True Crime Junkies Buy Sonar Boat to Solve Cold-Case Mysteriesby Lilu Anderson 06.04.2024True-crime enthusiasts take to cold cases, exploring disappearances. YouTube plays a key role as Florida's abundance of water piques interest. ...
New York Community Bancorp: Future Outlook After Recent Challengesby Mark Eisenberg 01.04.2024New York Community Bancorp faces challenges after purchasing another bank and difficulties with large loans. Recovery may take over a ...
Meta Platforms Stock: Ideal Buy Nowby Mark Eisenberg 31.03.2024More than 3.1 billion people rely on Meta's apps daily, appealing to a wide audience for leisure and professional use. ...
Is Buying Indian IT Stocks for FY25 a Wise Move?by Mark Eisenberg 30.03.2024Investing in Indian IT stocks for the long term can be wise, as they remain in base-building mode. Consider quality ...
Vaccine Investment Urgency: Why Isn’t More Being Done?by Terry Bingman 30.03.2024Cancel subscription renewal anytime, pay upfront for a year and save 20%, and enjoy the FT digital service. Discover why ...
Seattle businesses face turmoil amidst clash between app companies and delivery driversby Mark Eisenberg 30.03.2024Some delivery drivers are reporting improved pay while others say they are losing money. One suggestion is to reduce mileage ...
The Rise of WhatsApp: How It Became the Global Communication Leaderby Lilu Anderson 29.03.2024WhatsApp, with over 2 billion users worldwide, has become a pivotal platform for Meta. As the messaging app takes the ...
Congressional Plans for WuXi: Implications for Biotechby Lilu Anderson 29.03.2024Stay updated on the latest in biotech with our newsletter and podcast. Boundless becomes the ninth biotech company to go ...